David King — Independent Director at Cardinal Health

Mr. David P. King, also known as Dave, J.D. has been Chief Executive Officer and President at Laboratory Corporation of America Holdings since January 01, 2007. Mr. King has spent 17 years as a practicing attorney both in private practice and with the US Department of Justice. He has more than 25 years of experience in both the public and the private sector. He has a deep understanding of the clinical laboratory industry, business strategy, sales and marketing and executive management. He began his LabCorp tenure as General Counsel in 2001. He served as President of Esoterix, Inc. He served as the Chief Executive Officer of Cellmark Forensics, Inc. (Alternate name: Orchid Cellmark Inc). He served as the President of US LABS Inc. since October 2005. Mr. King served in the Department of Justice as an Assistant United States Attorney for 17 years and as a Partner in a private law firm. He served as an Executive Vice President and Chief Operating Officer of Laboratory Corporation of America Holdings from December 1, 2005 to January 2007. Mr. King served as the President of Integrated Oncology since October 2005. He served as an Executive Vice President of Strategic Planning and Corporate Development of Laboratory Corporation of America Holdings from January 2004 to December 1, 2005 and served as its Senior Vice President, General Counsel and Chief Compliance Officer since September 2001. Prior to joining the LabCorp, Mr. King was a Partner of Hogan & Hartson LLP from 1992 to 2001. He serves as the Chairman of the American Clinical Laboratory Association. Mr. King has been the Chairman of Laboratory Corp. of America Holdings since May 6, 2009. Mr. King served as the Chairman of the Board of Cellmark Forensics, Inc. He has been a Director of Laboratory Corporation of America Holdings since January 1, 2007. He also sits on the Boards of Directors of the Seattle Science Foundation and PATH, Inc. He serves as Member of Advisory Board at Grid Therapeutics, LLC. Mr. King serves as a Member of Board of Advisors at HealthQuest Capital. He serves on the Board of Trustees of Durham Academy. He has been an Independent Director at Cardinal Health, Inc. since September 1, 2011. Mr. King serves as a Director of Personalized Medicine Coalition. He was a Member of Scientific Advisory Board of Hatteras Venture Partners. Mr. King holds an AB degree from Princeton University and a Juris Doctorate from the University of Pennsylvania law School.